Company page

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Class A

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Class A, trading under the ticker 600329, operates in the Chinese pharmaceutical market. The company has a market capitalization of approximately 3.89 billion USD. It focuses on the development and production of traditional Chinese medicine and healthcare products.

profile600329AI content: aiUpdated May 29, 2026/company/tianjin-zhongxin-pharmaceutical-group-corp-ltd
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Class A logo
Ticker
600329
Market cap
$3.89B
Sector
Health Technology
Industry
Pharmaceuticals: Major